TAPI offers customized CDMO Solutions for API development and manufacturing services.
01 1TAPI Technology & API Services
02 1Acebright India Pharma Private Limited
03 1Alembic Pharmaceuticals Limited
04 1Apotex Pharmachem
05 1Asymchem Laboratories
06 1Cambrex Corporation
07 1Cdymax
08 1Cipla
09 1Esteve Huayi Pharmaceutical
10 1F.I.S. Fabbrica Italiana Sintetici
11 1Hetero Drugs
12 1Hikma Pharmaceuticals
13 1Intas Pharmaceuticals
14 1Laurus Labs
15 2MSN Laboratories
16 1Natco Pharma
17 1Qilu Antibiotics Pharmaceutical Co., Ltd.
18 1Reliance Life Sciences Private Limited
19 1Shilpa Medicare
20 1Sichuan Xieli Pharmaceutical
21 1Sun Pharmaceutical Industries Limited
22 1Tai Heng Industry Co., Ltd
23 2Viatris
24 1Zhejiang Jiuzhou Pharmaceutical
25 2Zydus Lifesciences
01 1ERLOTINIB HYDROCHLORIDE
02 1ERLOTINIB HCL
03 19ERLOTINIB HYDROCHLORIDE
04 1ERLOTINIB HYDROCHLORIDE (ET)
05 1ERLOTINIB HYDROCHLORIDE (FORM-A)
06 2ERLOTINIB HYDROCHLORIDE (FORM-B)
07 1ERLOTINIB HYDROCHLORIDE (NON-STERILE DRUG SUBSTANCE)
08 1ERLOTINIB HYDROCHLORIDE [DRUG SUBSTANCE (NON-STERILE)]
09 1ERLOTINIB HYDROCHLORIDE [ROUTE CODE - "ER"]
01 1Canada
02 6China
03 15India
04 1Israel
05 1Italy
06 3U.S.A
07 1United Kingdom
01 19Active
02 9Inactive
01 17Complete
02 11Blank
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-08
DMF Number : 23183
Submission : 2009-10-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-28
Pay. Date : 2012-12-12
DMF Number : 26631
Submission : 2013-01-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-16
Pay. Date : 2018-09-24
DMF Number : 29638
Submission : 2015-09-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-06-08
Pay. Date : 2016-04-22
DMF Number : 26116
Submission : 2012-06-04
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29437
Submission : 2015-05-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-08
Pay. Date : 2015-09-23
DMF Number : 27042
Submission : 2013-05-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-06-09
Pay. Date : 2015-05-27
DMF Number : 21786
Submission : 2008-07-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-03-05
Pay. Date : 2021-01-20
DMF Number : 25978
Submission : 2012-05-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-04
Pay. Date : 2015-04-10
DMF Number : 29124
Submission : 2015-04-13
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-01
Pay. Date : 2015-06-09
DMF Number : 26388
Submission : 2012-09-12
Status : Active
Type : II
A Erlotinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Erlotinib Hydrochloride, including repackagers and relabelers. The FDA regulates Erlotinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Erlotinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Erlotinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Erlotinib Hydrochloride supplier is an individual or a company that provides Erlotinib Hydrochloride active pharmaceutical ingredient (API) or Erlotinib Hydrochloride finished formulations upon request. The Erlotinib Hydrochloride suppliers may include Erlotinib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Erlotinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Erlotinib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Erlotinib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Erlotinib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Erlotinib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Erlotinib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Erlotinib Hydrochloride USDMF includes data on Erlotinib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Erlotinib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Erlotinib Hydrochloride suppliers with USDMF on PharmaCompass.
We have 25 companies offering Erlotinib Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?